Cardiac Troponin I Fast Test Kit
- UID
- IMP/IVD/2022/000153_f8c7374f2eecc42bbf5948d078992438_ae4c660edad7c125fca2f114eefad94c
- Device class
- Class C
- Brand name
- Immunofluorescence Assay
- License holder
- Cipla Limited
- Approving authority
- CDSCO
- Product information
- Cardiac Troponin I Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of Cardiac Troponin I (Immunofluorescence Assay) in serum, plasma or whole blood. This test is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (Immunofluorescence Assay), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (Immunofluorescence Assay).,hs-CRP+CRP Fast Test Kit (Immunofluorescence Assay)-hs-CRP+CRP Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of C-reactive protein (Immunofluorescence Assay) in human serum, plasma, whole blood or fingertip blood samples. Measurement of CRP is useful for the detection and evaluation of infection, tissue injury and inflammatory disorders. Measurement of high sensitivity CRP (Immunofluorescence Assay), when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes (Immunofluorescence Assay), may be useful as an independent marker of prognosis for recurrent events in patients with stable coronary disease or ACS
Cardiac Troponin I Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_f8c7374f2eecc42bbf5948d078992438_ae4c660edad7c125fca2f114eefad94c. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.